Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125858941 | 12585894 | 1 | I | 20160714 | 20160725 | 20160725 | EXP | CN-UCBSA-2016027273 | UCB | LIU X., ZHANG Y, SONG Y. CLINICAL ANALYSIS OF THREE PAEDIATRIC PATIENTS WITH MITOCHONDRIAL ENCEPHALOMYOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES (MELAS). CHINESE JOURNAL OF CONTEMPORARY NEUROLOGY AND NEUROSURGERY. 2016;16(5):291-6 | 9.00 | YR | F | Y | 15.50000 | KG | 20160725 | MD | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125858941 | 12585894 | 1 | PS | LEVETIRACETAM. | LEVETIRACETAM | 1 | Oral | 500 MG/DAY | U | 21035 | |||||||||
| 125858941 | 12585894 | 2 | C | TOPIRAMATE. | TOPIRAMATE | 1 | Oral | 75 MG/DAY | U | 0 | |||||||||
| 125858941 | 12585894 | 3 | C | Idebenone | IDEBENONE | 1 | Oral | 60 MG/DAY | U | 0 | |||||||||
| 125858941 | 12585894 | 4 | C | VITAMIN K1 | PHYTONADIONE | 1 | Intravenous (not otherwise specified) | 2 MG/DAY | U | 0 | |||||||||
| 125858941 | 12585894 | 5 | C | VITAMIN B2 | RIBOFLAVIN | 1 | Oral | 30 MG/DAY | U | 0 | |||||||||
| 125858941 | 12585894 | 6 | C | VITAMIN C | ASCORBIC ACID | 1 | Oral | 500 MG/DAY | U | 0 | |||||||||
| 125858941 | 12585894 | 7 | C | L-carnitine | LEVOCARNITINE | 1 | Oral | 1 G/DAY | U | 0 | |||||||||
| 125858941 | 12585894 | 8 | C | COENZYME Q10 | UBIDECARENONE | 1 | Oral | 30 MG/DAY | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125858941 | 12585894 | 1 | Epilepsy |
| 125858941 | 12585894 | 2 | Epilepsy |
| 125858941 | 12585894 | 3 | Product used for unknown indication |
| 125858941 | 12585894 | 4 | Product used for unknown indication |
| 125858941 | 12585894 | 5 | Product used for unknown indication |
| 125858941 | 12585894 | 6 | Product used for unknown indication |
| 125858941 | 12585894 | 7 | Product used for unknown indication |
| 125858941 | 12585894 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125858941 | 12585894 | DE |
| 125858941 | 12585894 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125858941 | 12585894 | Status epilepticus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125858941 | 12585894 | 1 | 200809 | 0 | ||
| 125858941 | 12585894 | 2 | 201109 | 0 |